Skip to main content

Table 3 Biochemical characteristics in MUAO and MHAO subjects

From: Association of proinflammatory genes expression with serum interleukin 1β and free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study

Variables

MUAO (n = 36)

MHAO (n = 34)

OR (95% CI)e

p

FBS (mg/dL)a

94.86 ± 1.57

89.91 ± 1.08

7.04 (1.42–34.69)*

0.012 c

TG (mg/dL)a

223.91 ± 13.50

136.11 ± 12.20

30.55 (7.48–60.67)*

< 0.001 c

HDL-C (mg/dL)a

40.08 ± 1.15

44.61 ± 1.60

0.22 (0.08–0.63)*

0.005 c

SBP (mmHg)a

116.14 ± 2.65

111.47 ± 2.39

3.31 (0.61–17.71)

0.197 c

DBP (mmHg)a

77.42 ± 2.57

75.00 ± 1.91

2.59 (0.71–9.42)

0.393 c

IL1β (pg/mL)b

756 (620.2–1877.2)

710.5 (621.2–872.2)

1.02 (0.94–1.11)

0.638d

FFAs (nmol/L)b

1326.5 (1116.5–5624.7)

1292 (1148.7–2595.7)

1.01 (0.99–1.02)

0.778d

  1. MHAO Metabolically Healthy Abdominally Obese, MUAO Metabolically Unhealthy Abdominally Obese, OR Odds Ratio, CI Confidence Interval, FBS Fasting Blood Sugar, TG Triglycerides, HDL-C High-Density Lipoprotein Cholesterol, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, IL1β interleukin 1 β, FFAs free fatty acids
  2. *p < 0.05
  3. a Data are reported as Mean ± standard deviation
  4. bData are reported as Median (25th, 75th)
  5. c Independent Samples t- test
  6. dMann-Whitney U test
  7. e ORs are calculated based on higher FBS, TG, Systolic PB, Diastolic BP, and lower HDL-C level